000 01491 a2200421 4500
005 20250516175953.0
264 0 _c20140715
008 201407s 0 0 eng d
022 _a1744-8298
024 7 _a10.2217/fca.13.67
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aBliden, Kevin P
245 0 0 _aPA tablets: investigational compounds combining aspirin and omeprazole for cardioprotection.
_h[electronic resource]
260 _bFuture cardiology
_cNov 2013
300 _a785-97 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAdministration, Oral
650 0 4 _aAspirin
_xadministration & dosage
650 0 4 _aBiological Availability
650 0 4 _aCardiovascular Diseases
_xmetabolism
650 0 4 _aDelayed-Action Preparations
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aDrug Interactions
650 0 4 _aDrug Therapy, Combination
650 0 4 _aHumans
650 0 4 _aOmeprazole
_xadministration & dosage
650 0 4 _aPlatelet Aggregation Inhibitors
_xadministration & dosage
650 0 4 _aProton Pump Inhibitors
_xadministration & dosage
650 0 4 _aTablets
700 1 _aBrener, Michael
700 1 _aGesheff, Martin G
700 1 _aFranzese, Christopher J
700 1 _aTabrizchi, Ali
700 1 _aTantry, Udaya
700 1 _aGurbel, Paul A
773 0 _tFuture cardiology
_gvol. 9
_gno. 6
_gp. 785-97
856 4 0 _uhttps://doi.org/10.2217/fca.13.67
_zAvailable from publisher's website
999 _c23221424
_d23221424